Literature DB >> 12180983

Characterization of the 5' untranslated region of alpha and beta isoforms of the human thromboxane A2 receptor (TP). Differential promoter utilization by the TP isoforms.

Adrian T Coyle1, Sinead M Miggin, B Therese Kinsella.   

Abstract

In humans, thromboxane (TX) A2 signals through two TXA2 receptor (TP) isoforms, TPalpha and TPbeta, that diverge within their carboxyl terminal cytoplasmic (C) tail regions and arise by differential splicing. The human TP gene contains three exons E1-E3; while E1 exclusively encodes 5' untranslated region (UTR) sequence, E2 and E3 represent the main coding exons. An additional noncoding exon, E1b was identified within intron 1. Additionally, the TP gene contains two promoters P1 and P2 located 5' of E1 and E1b, respectively. Herein, we investigated the molecular basis of the differential expression of the TP isoforms by characterizing the 5' UTR of the TP transcripts. While E1 and E1b were found associated with TP transcript(s), their expression was mutually exclusive. 5' rapid amplification of cDNA ends (5' RACE) established that the major transcription initiation (TI) sites were clustered between -115 and -92 within E1 and at -99 within E1b. While E1 and E1b sequences were identified on TPalpha transcript(s), neither existed on TPbeta transcript(s). More specifically, TPalpha and TPbeta transcripts diverged within E2 and the major TI sites for TPbeta transcripts mapped to -12/-15 therein. Through genetic reporter assays, a previously unrecognized promoter, termed P3, was identified on the TP gene located immediately 5' of -12. The proximity of P3 to the TI site of TPbeta suggests a role for P3 in the control of TPbeta expression and implies that TPalpha and TPbeta, in addition to being products of differential splicing, are under the transcriptional control of distinct promoters.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12180983     DOI: 10.1046/j.1432-1033.2002.03098.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  12 in total

1.  Thromboxane and the thromboxane receptor in cardiovascular disease.

Authors:  Emer M Smyth
Journal:  Clin Lipidol       Date:  2010-04-01

2.  Identification of an interaction between the TPalpha and TPbeta isoforms of the human thromboxane A2 receptor with protein kinase C-related kinase (PRK) 1: implications for prostate cancer.

Authors:  Elizebeth C Turner; David J Kavanagh; Eamon P Mulvaney; Caitriona McLean; Katarina Wikström; Helen M Reid; B Therese Kinsella
Journal:  J Biol Chem       Date:  2011-02-28       Impact factor: 5.157

3.  Palmitoylation of the TPbeta isoform of the human thromboxane A2 receptor. Modulation of G protein: effector coupling and modes of receptor internalization.

Authors:  Helen M Reid; B Therese Kinsella
Journal:  Cell Signal       Date:  2006-12-12       Impact factor: 4.315

4.  EP1- and FP-mediated cross-desensitization of the alpha (alpha) and beta (beta) isoforms of the human thromboxane A2 receptor.

Authors:  Leanne P Kelley-Hickie; B Therese Kinsella
Journal:  Br J Pharmacol       Date:  2004-04-20       Impact factor: 8.739

5.  Intermolecular cross-talk between the prostaglandin E2 receptor (EP)3 of subtype and thromboxane A(2) receptor signalling in human erythroleukaemic cells.

Authors:  Helen M Reid; B Therese Kinsella
Journal:  Br J Pharmacol       Date:  2009-08-20       Impact factor: 8.739

6.  Protein kinase C-related kinase 1 and 2 play an essential role in thromboxane-mediated neoplastic responses in prostate cancer.

Authors:  Aine G O'Sullivan; Eamon P Mulvaney; Paula B Hyland; B Therese Kinsella
Journal:  Oncotarget       Date:  2015-09-22

7.  Differential regulation of RhoA-mediated signaling by the TPalpha and TPbeta isoforms of the human thromboxane A2 receptor: independent modulation of TPalpha signaling by prostacyclin and nitric oxide.

Authors:  Katarina Wikström; David J Kavanagh; Helen M Reid; B Therese Kinsella
Journal:  Cell Signal       Date:  2008-05-23       Impact factor: 4.315

8.  MAPK signaling pathway regulates cerebrovascular receptor expression in human cerebral arteries.

Authors:  Saema Ansar; Sajedeh Eftekhari; Roya Waldsee; Elisabeth Nilsson; Ola Nilsson; Hans Säveland; Lars Edvinsson
Journal:  BMC Neurosci       Date:  2013-01-23       Impact factor: 3.288

9.  Homologous desensitization of signalling by the alpha (alpha) isoform of the human thromboxane A2 receptor: a specific role for nitric oxide signalling.

Authors:  Leanne P Kelley-Hickie; Martina B O'Keeffe; Helen M Reid; B Therese Kinsella
Journal:  Biochim Biophys Acta       Date:  2007-03-28

10.  The Wilms' tumour suppressor protein WT1 acts as a key transcriptional repressor of the human thromboxane A2 receptor gene in megakaryocytes.

Authors:  AnneMarie M Gannon; B Therese Kinsella
Journal:  J Cell Mol Med       Date:  2009 Nov-Dec       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.